EGFR and neoplasm: Consistently, p-ERK1/2, a known downstream effector of EGFR signalling, was higher in mPGES-1SC than mPGES-1KD tumours (Fig. 6D), suggesting that EGFR signalling plays a role in mPGES-1 enhancement of tumour growth.